Prosecution Insights
Last updated: October 04, 2026

Ibentrus Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Ibentrus Inc. maintains a portfolio in the Biotechnology & Pharmaceuticals sector with 1 pending office action. Prosecution activity is currently limited to a distinct examiner and 1 distinct art unit. This narrow focus reflects a concentrated effort in the company's active patent filings.

The busiest examiner assigned to the portfolio is DAHLE, CHUN WU, who holds the pending office action. Given that the total number of pending office actions is limited, this examiner manages the entire active workload. The presence of 1 distinct art unit indicates that the current prosecution is confined to a technical area within the patent office.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DAHLE, CHUN WU 1 50.2% +51.2%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
16317987 BISPECIFIC PROTEINS AND METHODS FOR PREPARING SAME DAHLE, CHUN WU 43d

Top Art Units

Art UnitApps
1641 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
16317987 BISPECIFIC PROTEINS AND METHODS FOR PREPARING SAME DAHLE, CHUN WU 1641 §103 Non-Final OA 43d Pending Jan 15, 2019

Managing Ibentrus Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month